Literature DB >> 1711540

Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor.

A Dobrina1, R Menegazzi, T M Carlos, E Nardon, R Cramer, T Zacchi, J M Harlan, P Patriarca.   

Abstract

We have examined the mechanisms involved in the adherence of normal peripheral blood eosinophils to cultured human umbilical vein endothelial cells (HEC) under three conditions: (a) adherence in the absence of treatment of HEC or eosinophils with activating agents (basal adherence); (b) adherence induced by stimulation of eosinophils with phorbol ester (eosinophil-dependent adherence); and (c) adherence induced by pretreatment of HEC with LPS, tumor necrosis factor (TNF), or IL-1 (endothelial-dependent adherence). A mechanism was identified that was equally active in basal, eosinophil-dependent, and endothelial-dependent adherence. This mechanism was optimally active in the presence of both Ca++ and Mg++, and reduced in the presence of Ca++ only or Mg++ only. Furthermore, like the other mechanisms of eosinophil adherence, it was active at 37 degrees C but not at 4 degrees C. A second mechanism of adherence was involved in eosinophil- and in endothelial-dependent adherence. This mechanism was dependent on the CD11/CD18 adhesion complex of eosinophils (i.e., inhibited by anti-CD18 MAb) and it was active in the presence of Ca++ and Mg++ or Mg++ only, but not Ca++ only. The third mechanism of adherence was specific for endothelial-dependent adherence. It involved the endothelial ligand vascular cell adhesion molecule-1 (VCAM-1) and the eosinophil receptor very late activation antigen-4 (VLA-4, CD49d/CD29, i.e., inhibited by anti-VCAM-1 MAb or anti-VLA-4 MAb). This mechanism was active in the presence of Ca++ and Mg++ but not of Ca++ only or Mg++ only, and was not up- or downregulated when eosinophils were stimulated with phorbol ester. In contrast, the endothelial leukocyte adhesion molecule-1 (ELAM-1), that binds neutrophils and monocytes, was not involved in eosinophil adherence to LPS-, TNF-, or IL-1-stimulated HEC (i.e., not inhibited by anti-ELAM-1 MAb). We conclude that eosinophils, like monocytes and lymphocytes, bind to the cytokine-induced endothelial ligand VCAM-1 via the integrin receptor VLA-4.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711540      PMCID: PMC295997          DOI: 10.1172/JCI115278

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

Review 1.  The eosinophil, eosinophilia, and eosinophil-related disorders. III. Clinical assessments and eosinophil related disorders.

Authors:  T B Nutman; E A Ottesen; S G Cohen
Journal:  Allergy Proc       Date:  1989 Jan-Feb

Review 2.  The eosinophil, eosinophilia, and eosinophil-related disorders. IV. Eosinophil related disorders (continued).

Authors:  T B Nutman; E A Ottesen; S G Cohen
Journal:  Allergy Proc       Date:  1989 Jan-Feb

3.  VLA-3: a novel polypeptide association within the VLA molecular complex: cell distribution and biochemical characterization.

Authors:  F Sánchez-Madrid; M O De Landázuri; G Morago; M Cebrián; A Acevedo; C Bernabeu
Journal:  Eur J Immunol       Date:  1986-11       Impact factor: 5.532

4.  CD11/CD18-independent neutrophil adherence to inducible endothelial-leucocyte adhesion molecules (E-LAM) in vitro.

Authors:  A Dobrina; B R Schwartz; T M Carlos; H D Ochs; P G Beatty; J M Harlan
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

5.  Human eosinophilic peroxidase: role in bactericidal activity.

Authors:  R Migler; L R DeChatelet; D A Bass
Journal:  Blood       Date:  1978-03       Impact factor: 22.113

6.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

7.  Cytotoxic properties of the eosinophil major basic protein.

Authors:  G J Gleich; E Frigas; D A Loegering; D L Wassom; D Steinmuller
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

8.  Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.

Authors:  A J Wardlaw; R Moqbel; O Cromwell; A B Kay
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

9.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

10.  Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes.

Authors:  L Osborn; C Hession; R Tizard; C Vassallo; S Luhowskyj; G Chi-Rosso; R Lobb
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

View more
  48 in total

1.  Intercellular adhesion molecule-1 on eosinophils is involved in eosinophil protein X release induced by cytokines.

Authors:  S Horie; Y Okubo; M Hossain; T Momose; J Suzuki; M Isobe; M Sekiguchi
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

Review 2.  Recent advances in asthma.

Authors:  P J Barnes; T H Lee
Journal:  Postgrad Med J       Date:  1992-12       Impact factor: 2.401

Review 3.  The role of CD15-(Le(X))-related carbohydrates in neutrophil adhesion.

Authors:  M A Kerr; S C Stocks
Journal:  Histochem J       Date:  1992-11

Review 4.  Leukocyte-endothelium interactions in cutaneous inflammatory processes.

Authors:  J N Barker; B J Nickoloff
Journal:  Springer Semin Immunopathol       Date:  1992

5.  Impaired immunity and altered pulmonary responses in mice with a disrupted interferon-gamma receptor gene exposed to the irradiated Schistosoma mansoni vaccine.

Authors:  R A Wilson; P S Coulson; C Betts; M A Dowling; L E Smythies
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

6.  The impact of eotaxin- and IL-5-induced adhesion and transmigration on eosinophil activity markers.

Authors:  E Fernvik; J Lundahl; G Halldén
Journal:  Inflammation       Date:  2000-02       Impact factor: 4.092

7.  Increased adhesion of human monocytes to IL-4-stimulated human venous endothelial cells via CD11/CD18, and very late antigen-4 (VLA-4)/vascular cell adhesion molecule-1 (VCAM-1)-dependent mechanisms.

Authors:  E M Verdegaal; H Beekhuizen; I Blokland; R van Furth
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

8.  Leptospira icterohemorrhagiae and leptospire peptidolgycans induce endothelial cell adhesiveness for polymorphonuclear leukocytes.

Authors:  A Dobrina; E Nardon; E Vecile; M Cinco; P Patriarca
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

9.  Effects of monoclonal antibodies to adhesion molecules on eosinophilic myocarditis in Toxocara canis-infected CBA/J mice.

Authors:  S Hokibara; M Takamoto; M Isobe; K Sugane
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

10.  Role of inflammation in nocturnal asthma.

Authors:  T W Mackay; W A Wallace; S E Howie; P H Brown; A P Greening; M K Church; N J Douglas
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.